Simple Sell Setup with a interesting Risk Ratio ( > 1:3 ). Details below or on chart:
FUNDAMENTAL NOTE:
Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company's products include Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Hepatitis C Franchise, Reyataz Franchise and Sustiva Franchise. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience, and cardiovascular. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world.
SETUP MODE
---------------------------------------
# ACCOUNT BALANCE: 10K #
---------------------------------------
- SELL AREA: 55.60/55.95
- STOP LOSS: 56.85
- TARGET: 52.00/51.50
=====================
MONEY MANAGEMENT
---------------------------------------
# SELL: 10.000$ (Risk: 3%) #
---------------------------------------
- SIZE: 200 lots/shares
- POTENTIAL LOSS: 300$
- POTENTIAL GAIN: 1.100$
TRADER NOTE:
Minimun Account: 1.000$ (20 lots/shares)
...Thank you for your support and trade with care!
FUNDAMENTAL NOTE:
Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company's products include Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Hepatitis C Franchise, Reyataz Franchise and Sustiva Franchise. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience, and cardiovascular. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world.
SETUP MODE
---------------------------------------
# ACCOUNT BALANCE: 10K #
---------------------------------------
- SELL AREA: 55.60/55.95
- STOP LOSS: 56.85
- TARGET: 52.00/51.50
=====================
MONEY MANAGEMENT
---------------------------------------
# SELL: 10.000$ (Risk: 3%) #
---------------------------------------
- SIZE: 200 lots/shares
- POTENTIAL LOSS: 300$
- POTENTIAL GAIN: 1.100$
TRADER NOTE:
Minimun Account: 1.000$ (20 lots/shares)
...Thank you for your support and trade with care!
注释
...pending order注释
Rebound in play... follow our idea!免责声明
这些信息和出版物并非旨在提供,也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
免责声明
这些信息和出版物并非旨在提供,也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
